DANIEL S. LYNCH
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
NOUBAR AFEYAN, PAUL BURGESS, OMID FAROKHZAD, OMID C. FAROKHZAD, ANDREA FRANZ, ANDREW HIRSCH, JEFFREY HRKACH, PETER BARTON HUTT, DANIEL KOERWER, ROBERT S LANGER, ROBERT LANGER, JR., ROBERT S. LANGER, JR., SCOTT MINICK, AMIR NASHAT, AMIR H. NASHAT, ED SCHNIPPER, EDWARD SCHNIPPER, YURIY UDALTSOV, JAMES WRIGHT, JIM WRIGHT, STEPHEN ZALE
DIRECTOR
NOUBAR B AFEYAN, DAVID A. BERRY, DAVID M BERRY, ABBIE C. CELNIKER, ABBIE C. CELNIKER, PH.D., PAUL CHANEY, PAUL G. CHANEY, LESLIE DAN, ARTHUR P. DECILLIS, WENDY L. DIXON, KIM C. DRAPKIN, JAY S. DUKER, RICHARD F. FITZGERALD, ERIC S. FURFINE, BARRY J. GERTZ, JANE V. HENDERSON, STEPHEN HURLY, STEPHEN A. HURLY, MARK LEVIN, JOHN MCCABE, GREGORY D. PERRY, CARY PFEFFER, CARY G. PFEFFER, KAREN L. TURBRIDY
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-09-10
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-05-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-21
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-12-02

